Seelos Therapeutics
SEEL
#10584
Rank
S$0.27 M
Marketcap
S$0.48
Share price
-31.49%
Change (1 day)
-98.19%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): S$6.01 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$48.74 Million, an increase over its 2022 earnings that were of -S$94.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$6.01 M-112.33%
2023 -S$48.74 Million-48.58%
2022 -S$94.78 Million14.07%
2021 -S$83.09 Million240.34%
2020 -S$24.42 Million-62.76%
2019 -S$65.56 Million587.73%
2018 -S$9.54 Million-36.54%
2017 -S$15.02 Million74.83%
2016 -S$8.6 Million-63.26%
2015 -S$23.39 Million-18.06%
2014 -S$28.54 Million46.19%
2013 -S$19.53 Million-31.67%
2012 -S$28.58 Million
2010 -S$26.77 Million448.63%
2009 -S$4.88 Million-25.83%
2008 -S$6.58 Million-45.65%
2007 -S$12.11 Million2.82%
2006 -S$11.77 Million-41.86%
2005 -S$20.25 Million-9.27%
2004 -S$22.31 Million114.92%
2003 -S$10.38 Million-70.78%
2002 -S$35.53 Million60.2%
2001 -S$22.18 Million70.3%
2000 -S$13.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA